Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
196
-
Total 13F shares, excl. options
-
80.5M
-
Shares change
-
-349K
-
Total reported value, excl. options
-
$1.59B
-
Value change
-
-$6.67M
-
Put/Call ratio
-
0.87
-
Number of buys
-
83
-
Number of sells
-
-106
-
Price
-
$19.80
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q4 2021
240 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q4 2021.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 196 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.5M shares
of 106M outstanding shares and own 76.06% of the company stock.
Largest 10 shareholders include BlackRock Inc. (15M shares), VANGUARD GROUP INC (10.8M shares), RENAISSANCE TECHNOLOGIES LLC (8.02M shares), INGALLS & SNYDER LLC (6.74M shares), FEDERATED HERMES, INC. (4.63M shares), MILLENNIUM MANAGEMENT LLC (3.33M shares), STATE STREET CORP (3.31M shares), DIMENSIONAL FUND ADVISORS LP (1.88M shares), Parallel Advisors, LLC (1.8M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.73M shares).
This table shows the top 196 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.